Key Highlights
- The Finnish wearable tech firm is preparing for a fall IPO with a target valuation exceeding $16 billion, representing a significant increase from its $10.9 billion private valuation
- Revenue figures show strong growth trajectory: $500 million in 2024, approximately $1 billion in 2025, with projections of $2 billion for 2026
- Traditional IPO offerings in the United States have already generated $137 billion this year, positioning 2026 for potential record-breaking activity
- AI startup Anthropic’s anticipated public offering could reach $100 billion, potentially eclipsing the 2021 market peak of $156 billion
- The wearable maker is defending against legal claims questioning the precision of its sleep monitoring technology
The Finnish health technology company Oura is preparing for a public market debut this fall, with plans to achieve a valuation surpassing $16 billion. This represents substantial growth from the $10.9 billion price tag attached to the company following its $875 million Series E funding round completed last September.
The smart ring manufacturer intends to secure approximately $3 billion through the public offering. A significant portion of the shares sold will come from existing stakeholders looking to liquidate their positions.
Confidential IPO documents were submitted by Oura in May. The organization maintains operational centers in both San Francisco and Finland, with a workforce exceeding 900 employees.
Financial Performance
According to company disclosures, Oura generated $500 million in revenue throughout 2024. This figure nearly doubled to approximately $1 billion in 2025, with internal forecasts projecting revenues approaching $2 billion by the end of 2026.
Additional financial metrics and operational details will be disclosed when the company publicly releases its S-1 registration statement.
What started as a specialized device marketed toward wellness enthusiasts and executives has transformed into a widely recognized sleep optimization and recovery tracking brand. The company now competes against Samsung’s Galaxy Ring and fitness tracking company Whoop, which secured a $10 billion valuation this past March.
Litigation Challenges
Recent developments haven’t been entirely favorable for the wearable technology firm. Last week, a proposed class action complaint was lodged in San Francisco, alleging that the company provided misleading information regarding its sleep tracking accuracy.
The legal filing asserts that Oura exaggerated its capability to accurately identify different sleep stages, a function that traditionally requires sophisticated clinical instruments including scalp electrodes and ocular monitoring devices.
In response, Oura has defended its technology, citing multiple independent research studies that validated its sleep stage detection capabilities and demonstrated favorable comparisons with polysomnography, the industry-accepted clinical benchmark for sleep analysis.
Robust IPO Pipeline
Oura joins a growing list of enterprises preparing for public market debuts in the upcoming months. Inspire Brands, which operates popular restaurant chains including Dunkin’ and Arby’s, is also targeting an offering in late 2026.
Infrastructure companies Switch and SB Energy are currently conducting investor presentations in preparation for possible stock market launches. Artificial intelligence firm Anthropic’s anticipated IPO could generate up to $100 billion in proceeds, which would propel 2026 far beyond the previous 2021 benchmark of $156 billion in total capital raised.
This year’s newly public companies have demonstrated strong market performance, with share prices averaging 21% gains above their initial offering prices, based on Dealogic analytics.
SpaceX’s massive $86 billion June public offering helped pave the way for subsequent listings, despite the company’s shares retreating to their initial offering price.
OpenAI is also evaluating a potential listing, though timing may extend into 2027. The artificial intelligence leader recently informed stakeholders that quarterly revenue expanded 18% between Q1 and Q2, although operating losses widened during the same period.


